References
Hashimoto H. 1912 Zur Kenntniss der lymphomatösen Veränderung der Schilddrüse (struma lymphomatosa). Arch Klin Chir 97: 219–248.
Hashimoto K, 2002 My father and his teacher. Endocr J 49: 389–391.
Amino N, Tada H, Hidaka Y, et al, 2002 Hashimoto’s disease and Dr. Hakaru Hashimoto. Endocr J 49: 393–397.
Sawin CT, 2002 The heritage of Dr. Hakaru Hashimoto (1881–1934). Endocr J 49: 399–403.
Satoh H, 2011 The history of Hashimoto disease: The establishment of a new diagnosis “Hashimoto disease” with a biography of Hakaru Hashimoto and a brief history of Fukuoka Medical College. In: Commemorative article of a centennial of Hashimoto disease in the Bulletin of the 1st Department of Surgery, Kyushu University, pp 9–21.
Simmonds M, 1913 Über lymphatische Herde in der Schilddrüse. Virch Arch Patholog Anat Physiol 211: 73–89.
Heineke, 1914 Die chronische Thyreoiditis. Deut Zeit Chir 129: 189–220.
Reist A, 1922 Über chronische Thyreoiditis. Frankf Zeit f Pathol 28: 141–200.
Riedel BM, 1896 Die chronische zur Bildung eisenharter Tumoren führende Entzündung der Schilddruese. Verh Ges Chir 25:101–105.
Graham A, 1931 Riedel’s struma in contrast to struma lymphomatosa (Hashimoto). West J Surg 39: 681–689.
Rose NR, Witebsky E, 1956 Studies on organ specificity: V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts. J Immunol 76: 417–427.
Witebsky E, Rose NR, Paine JR, et al, 1957 Thyroid-specific autoantibodies. Ann N Y Acad Sci 69: 669–677.
Campbell PN, Doniach D, Hudson RV, et al, 1956 Auto-antibodies in Hashimoto’s disease (lymphadenoid goitre). Lancet 271: 820–821.
Doniach D, Roitt IM, 1962 Hakaru Hashimoto. Lancet 1074.
Jameson JL, Weetman AP, 2012 Disorders of the Thyroid glands. In: Dan Longo, Anthony Fauci, Dennis Kasper, Stephen Hauser, J. Jameson, Joseph Loscalzo (eds) Harrison’s Principles of Internal Medicine, 18th edition. McGraw Hill Medical Companies. pp. 2911–2939.
Amino N, Hagen SR, Yamada N, et al, 1976 Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases. Clin Endocrinol (Oxf) 5: 115–125.
Brent GA, Davies TF, 2011 Hypothyroidism and thyroiditis. In: Shlomo Melmed, Kenneth S. Polonsky MD, P. Reed MD Larsen, Henry M. Kronenberg MD (eds) Williams Textbook of Endocrinology, 12th Edition, pp 406–439.
Amino N, Mori H, Iwatani Y, et al, 1982 High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N Engl J Med 306: 849–852.
Akamizu T, Amino N, DeGroot LJ, 2012 Hashimoto’s thyroiditis. In: Thyroid Disease Manager (https://doi.org/www.thyroidmanager.org/chapter/hashimotos-thyroiditis/)
Hasham A, Tomer Y, 2012 Genetic and epigenetic mechanisms in thyroid autoimmunity. Immunol Res 54: 204–213.
Brix TH, Kyvik KO, Hegedüs L. 2000 A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 85:536–539.
Menconi F, Monti MC, Greenberg DA, et al, 2008 Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc Natl Acad Sci USA 105: 14034–14039.
Stefan M, Jacobson EM, Huber AK, et al, 2011 Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism. J Biol Chem 286: 31168–31179.
Jacobson EM, Huber AK, Akeno N, et al, 2007 A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun 8: 205–214.
Tomer Y, 2010 Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid 20: 715–725.
Saitoh O, Nagayama Y, 2006 Regulation of Graves’ hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model. Endocrinology 147: 2417–2422.
McLachlan SM, Nagayama Y, Pichurin PN, et al, 2007 The link between Graves’ disease and Hashimoto’s thyroiditis: a role for regulatory T cells. Endocrinology 148: 5724–5733.
Burek CL, Talor MV, 2009 Environmental triggers of autoimmune thyroiditis. J Autoimmun 33: 183–189.
Duntas LH, 2008 Environmental factors and autoimmune thyroiditis. Nat Clin Pract Endocrinol Metab 4: 454–460.
Saranac L, Zivanovic S, Bjelakovic B, et al, 2011 Why is the thyroid so prone to autoimmune disease? Horm Res Paediatr 75: 157–165.
Morohoshi K, Takahashi Y, Mori K, 2011 Viral infection and innate pattern recognition receptors in induction of Hashimoto’s thyroiditis. Discov Med 12: 505–511.
Giordano C, Stassi G, De Maria R, et al, 1997 Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto’s thyroiditis. Science 275: 960–963.
Zaletel K, Gaberšček S, 2011 Hashimoto’s Thyroiditis: From Genes to the Disease. Curr Genomics 12: 576–588.
Amino N, Tada H, Hidaka Y, 1999 Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid 9: 705–713.
Katz SM, Vickery AL Jr, 1974 The fibrous variant of Hashimoto’s thyroiditis. Hum Pathol 5: 161–170.
Ahmed R, Al-Shaikh S, Akhtar M, 2012 Hashimoto thyroiditis: a century later. Adv Anat Pathol 19: 181–186.
Hennessey JV, 2011 Clinical review: Riedel’s thyroiditis: a clinical review. J Clin Endocrinol Metab 96: 3031–3041.
Hay ID, 1985 Thyroiditis: a clinical update. Mayo Clin Proc 60: 836–843.
Stone JH, Khosroshahi A, Deshpande V, et al, 2012 IgG4-Related disease: recommendations for the nomenclature of this condition and its individual organ system manifestations. Arthritis Rheum 64: 3061–3067.
Kakudo K, Li Y, Taniguchi E, et al, 2012 IgG4-related disease of the thyroid glands. Endocr J 59: 273–281.
Deshpande V, Huck A, Ooi E, et al, 2012 Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease. J Clin Pathol 65: 725–728.
Tamaki H, Amino N, Kimura M, et al, 1990 Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan. J Clin Endocrinol Metab 71: 1382–1386.
Brain L, Jellinek EH, Ball K, 1966 Hashimoto’s disease and encephalopathy. Lancet 2: 512–514.
Schiess N, Pardo CA, 2008 Hashimoto’s encephalopathy. Ann N Y Acad Sci 1142: 254–265.
Yoneda M, Fujii A, Ito A, et al, 2007 High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto’s encephalopathy. J Neuroimmunol 185: 195–200.
Mack LA, Pasieka JL, 2007 An evidence-based approach to the treatment of thyroid lymphoma. World J Surg 31: 978–986.
Ahn D, Heo SJ, Park JH, et al, 2011 Clinical relationship between Hashimoto’s thyroiditis and papillary thyroid cancer. Acta Oncol 50: 1228–1234.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hiromatsu, Y., Satoh, H. & Amino, N. Hashimoto’s Thyroiditis: History and Future Outlook. Hormones 12, 12–18 (2013). https://doi.org/10.1007/BF03401282
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03401282